A recent press release reports, “Specialty diagnostics company Precipio, Inc., announced today an agreement with Israel-based artificial intelligence pathology platform company Nucleai who specializes in applying Machine Learning and Machine Vision algorithms to pathology domain. Nucleai’s experienced team has adapted artificial intelligence technology previously used for satellite image analysis to the detection of cancer using […]